Enzymes: Still cool after all these years
The first enzyme was discovered in 1833, almost 200 years ago and long before the nature of proteins was appreciated. The field of enzymology came into its own in the 20th century. Technological advances in the hands of creative enzymologists led to an ever-growing understanding of how enzymes achieve enormous rate accelerations as well as the structural basis for substrate specificity and allosteric regulation.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
Enzymologists continue to break new ground as we enter the 21st century. Our session at Discover BMB will feature new work on enzyme functions, mechanisms and applications.
Our first group of speakers will focus on enzymes that deal with problems caused by misbehaving metabolites. They will describe how enzymes can protect unstable intermediates and repair damaged metabolites. Our second group will explore the potential of using enzymes for biodegradation and green biosynthesis of chemicals currently produced from petrochemicals. Our final group will focus on enzymes that catalyze novel reactions, pushing the boundaries of chemistry accessible through biocatalysts.
Keywords: Substrate channeling, metabolite repair, biodegradation, green chemistry, natural product biosynthesis, radical chemistry.
Who should attend: Anyone who appreciates the awesome power of enzyme catalysis.
Theme song: “Still Crazy After All These Years” by Paul Simon, because enzymes are crazy-efficient catalysts
This session is powered by the ribosome, which produces the enzymes that make life possible.
Cool and novel enzymes
Enzymatic control of problematic intermediates
Chair: Hung-Wen (Ben) Liu
Shelley D. Copley, University of Colorado Boulder
Tom Niehaus, University of Minnesota, Twin Cities
Shelley Minteer, University of Utah
Carole Linster, University of Luxembourg
Enzymes for a sustainable future
Chair: Shelley D. Copley
Gregg Beckham, National Renewable Energy Laboratory
Larry Wackett, University of Minnesota
Michelle Chang, University of California, Berkeley
Raquel Lieberman, Georgia Institute of Technology
New and unusual enzymatic transformations
Chair: Michelle Chang
Hung-wen (Ben) Liu, University of Texas at Austin
Aimin Liu, University of Texas at San Antonio
Sara O'Connor, Max Planck Institute for Chemical Ecology
Wenjun Zhang, University of California, Berkeley
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Transforming learning through innovation and collaboration
Neena Grover will receive the William C. Rose Award for Exemplary Contributions to Education at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.